A CASE FOR ALTERNATIVE THERAPIES
The Dengvaxia vaccine is “the biggest government funded clinical-trial-masked-as-a-public-health-program scam of an experimental drug in the history of the DOH.”
It’s a damning charge made by Dr. Susan Pineda-Mercado, former DOH undersecretary and international public health expert. it is an indictment of our health care system—the politics, the lobbying, the sway of big pharma, the conflicts of interests, and possible complicity of many in fast-tracking and green-lighting the processes of exemption, procurement and purchase of the vaccine.
Rep. Estrelita Suansing supports the charge with comments that were no less forgiving: that approval and P3B budget allocation for the vaccine purchase seemed hasty and impulsive. . . that the fund source might not have undergone Congressional scrutiny . .that the purchase was not included in the General Appropriations Act (GAA) of 2015. Others in the medical community concurred the vaccine program had misplaced priorities, procedural lapses, and conflicts of interest.
Even after the approval was criticized as hasty and impulsive, there were signs early on that the vaccine was laden with problems. The public health community has been outraged for a year, said Dr.Mercado. Why did it take so long to take it down? Why did it have to wait for Sanofi’s confessional?